Healthcare Services

Herceptin Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Herceptin Market Evolve From 2026 To 2030?

The herceptin market size has demonstrated significant growth recently. It is projected to increase from $7.48 billion in 2025 to $7.92 billion in 2026, at a compound annual growth rate (CAGR) of 5.8%. This historical expansion can be attributed to the expansion of her2-positive cancer diagnosis, widespread clinical acceptance of trastuzumab, growth in oncology infusion infrastructure, availability of biologic manufacturing capabilities, and the inclusion of herceptin in standard treatment guidelines.

The herceptin market is anticipated to experience substantial expansion over the coming years. By 2030, its valuation is projected to reach $9.92 billion, expanding at a compound annual growth rate (CAGR) of 5.8%. This projected growth is driven by factors such as intensified biosimilar rivalry, a greater need for cost-effective biologic treatments, the broadening of targeted oncology development, the increasing embrace of individualized cancer therapy, and augmented investment in biologic drug innovation. Key trends foreseen include the wider acceptance of biosimilar trastuzumab offerings, the expanding utilization of subcutaneous drug forms, the broadening of multi-drug treatment approaches, a heightened emphasis on economical biologic options, and improved oversight of treatment results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24236&type=smp

What Drivers Are Influencing The Herceptin Market?

The rising occurrence of breast cancer is anticipated to drive the expansion of the herceptin market in the future. Breast cancer is defined as a malignancy originating in breast cells, typically within the milk ducts or lobules, and includes invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and HER2-positive breast cancer. An increase in breast cancer cases can be partially attributed to evolving lifestyle factors, such as higher alcohol intake, unhealthy diets, and insufficient physical exercise, all of which elevate risk. With a growing number of breast cancer diagnoses, especially those identified as HER2-positive, the need for potent targeted treatments like herceptin steadily increases. For instance, the American Cancer Society, a US-based cancer organization, estimated in January 2025 that 319,750 new cases of breast cancer are anticipated for 2025, alongside a projection of around 42,680 fatalities from the illness. Consequently, the growing prevalence of breast cancer is a significant factor in the herceptin market’s growth.

Which Segment Areas Are Covered In The Herceptin Market Analysis?

The herceptin market covered in this report is segmented –

1) By Product: Biologic, Biosimilar

2) By Application: Breast Cancer, Gastric Cancer

3) By Payer: Commercial And Private, Public

4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy

Subsegments:

1) By Biologic: Intravenous (IV) Biologics, Subcutaneous (SC) Biologic

2) By Biosimilar: Intravenous (IV) Biosimilars, Subcutaneous (SC) Biosimilars

What Industry Trends Are Redefining The Herceptin Market?

Leading companies in the herceptin market are developing innovative treatment options, such as advanced biosimilar products, to improve patient access and therapeutic outcomes for HER2-positive cancers. These innovative biosimilar products are highly similar versions of approved biologic drugs, developed using sophisticated biotechnology to ensure comparable safety, efficacy, and quality. For example, in April 2024, Accord BioPharma Inc., a US-based pharmaceutical company, received approval from the U.S. Food and Drug Administration for HERCESSI (trastuzumab-strf), a biosimilar to herceptin (trastuzumab), intended for the treatment of HER2-overexpressing breast and gastric cancers. Biosimilars like HERCESSI demonstrate similar efficacy and safety to their reference biologics while potentially offering more cost-effective treatment choices.

Which Global Companies Are Actively Competing In The Herceptin Market?

Major companies operating in the herceptin market are Roche Holding AG, Pfizer Inc., Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Biocon Limited, Dr. Reddy’s Laboratories, Celltrion Inc., Samsung Biologics, Fresenius Kabi, Intas Pharmaceuticals Ltd, Zydus Lifesciences Ltd, AryoGen Pharmed, Shanghai Henlius Biotech Inc., Prestige Biopharma Pte Ltd, Alvotech, Coherus BioSciences, BioXpress Therapeutics, Amneal Pharmaceuticals, Novartis AG

Read the full herceptin market report here:

https://www.thebusinessresearchcompany.com/report/herceptin-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Herceptin Market?

North America was the largest region in the herceptin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herceptin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Herceptin Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24236&type=smp

Browse Through More Reports Similar to the Global Herceptin Market 2026, By The Business Research Company

Oleoresin Global Market Report

https://www.thebusinessresearchcompany.com/report/oleoresin-global-market-report

Epinephrine Global Market Report

https://www.thebusinessresearchcompany.com/report/epinephrine-global-market-report

Genital Herpes Global Market Report

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795